Clinical Trials Directory

Trials / Sponsors / WestVac Biopharma Co., Ltd.

WestVac Biopharma Co., Ltd.

Industry · 13 registered clinical trials — 4 currently recruiting.

StatusTrialPhaseStarted
Not Yet RecruitingA Phase 1 Clinical Study to Evaluate the Safety and Efficacy of WSK-IM02 in Patients With Platinum-resistant R
Platinum-resistant Recurrent Ovarian Cancer (PROC)
Phase 12026-03-10
RecruitingA Phase 2b Clinical Study of JDB0131 Benzenesulfonate Tablets
Tuberculosis, Multidrug Resistant Pulmonary Tuberculosis, Rifampicin-resistant Tuberculosis
Phase 22025-09-19
Not Yet RecruitingA Phase Ⅲ Clinical Trial of Recombinant COVID-19 Trivalent (XBB+BA.5+Delta) Protein Vaccine (Sf9 Cell) in Boos
COVID-19
Phase 32024-12-30
Not Yet RecruitingA Clinical Trial of Recombinant COVID-19 Bivalent (XBB+Prototype) Protein Vaccine (Sf9 Cell) in Booster Vaccin
COVID-19
Phase 22024-12-30
WithdrawnClinical Trial of Recombinant COVID-19 Vaccine (Sf9 Cells) in Children and Adolescents
COVID-19
Phase 1 / Phase 22024-07-01
UnknownA Phase 3 Clinical Study to Evaluate the Efficacy, Safety and Immunogenicity of Booster Vaccination With Recom
COVID-19
Phase 32023-12-19
WithdrawnSafety and Immunogenicity of Recombinant COVID-19 Variant Vaccine (Sf9 Cell) as a Booster
COVID-19, SARS-CoV-2 Infection
Phase 22023-07-07
CompletedPhase II Clinical Trial of Recombinant COVID-19 Variant Vaccine (Sf9 Cell)
COVID-19
Phase 22023-03-30
CompletedPhase I Clinical Trial of Recombinant COVID-19 Variant Vaccine (Sf9 Cell) (WSK-V102)
COVID-19
Phase 12023-03-14
CompletedA Clinical Study to Evaluate the Safety and Immunogenicity of the Recombinant COVID-19 Vaccine (Sf9 Cell) as a
COVID-19, SARS-CoV-2 Infection
N/A2022-08-02
CompletedA Clinical Trial of Immuno-bridging Between Different Manufacture Scales of Recombinant COVID-19 Vaccine (Sf9
COVID-19, SARS-CoV-2 Pneumonia
N/A2022-07-20
CompletedSafety and Immunogenicity of Recombinant COVID-19 Vaccine (Sf9 Cell) as a Booster
COVID-19, SARS-CoV-2 Infection
Phase 22022-07-11
CompletedA Global Phase III Clinical Trial of Recombinant COVID- 19 Vaccine (Sf9 Cells)
COVID-19
Phase 32021-06-15